BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 5576948)

  • 1. [Biochemical, histological and clinical findings in carriers of Duchenne-type progressive muscular dystrophy].
    Moser H; Mumenthaler M; Wiesmann U
    Schweiz Med Wochenschr; 1971 Apr; 101(15):537-42. PubMed ID: 5576948
    [No Abstract]   [Full Text] [Related]  

  • 2. Carrier detection in X-linked muscular dystrophy.
    Walton JN
    J Genet Hum; 1969 Oct; 17(3):497-510. PubMed ID: 5387424
    [No Abstract]   [Full Text] [Related]  

  • 3. [Identification of the carrier state in the severe recessive X-linked muscular dystrophy (Duchenne type). I. Assay of activated serum creatine kinase activity in serum (author's transl)].
    Rotthauwe HW; Kowalewski S
    Z Kinderheilkd; 1973 Nov; 115(4):333-42. PubMed ID: 4591596
    [No Abstract]   [Full Text] [Related]  

  • 4. Limb-girdle muscular dystrophy: clinical manifestations and detection of preclinical disease.
    Jackson CE; Strehler DA
    Pediatrics; 1968 Feb; 41(2):495-502. PubMed ID: 5637795
    [No Abstract]   [Full Text] [Related]  

  • 5. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
    Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
    Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
    Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Muscle LDH isoenzymes in neuromuscular diseases and in carriers of recessive X-linked muscular dystrophy (duchenne)].
    Kowalewski S; Rotthauwe HW
    Z Kinderheilkd; 1972; 113(1):55-70. PubMed ID: 5056500
    [No Abstract]   [Full Text] [Related]  

  • 8. [Present-day clinico-genetic framework of Duchenne's muscular dystrophy].
    Meola G
    Riv Neurol; 1989; 59(1):8-14. PubMed ID: 2669113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creatine-phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: a Brazilian study.
    Zatz M; Frota-Pessoa O; Levy JA; Peres CA
    J Genet Hum; 1976 Jun; 24(2):153-68. PubMed ID: 965952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis between Duchenne and Becker types muscular dystrophy.
    Ishpekova B; Milanov I; Christova LG; Alexandrov AS
    Electromyogr Clin Neurophysiol; 1999; 39(5):315-8. PubMed ID: 10422002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood enzymes in Duchene's progressive muscular dystrophy and their correlation with the clinical and histological pictures.
    Niebrój-Dobosz I; Jedrzejowska H; Hetnarska L
    Acta Med Pol; 1970; 11(4):387-93. PubMed ID: 5493781
    [No Abstract]   [Full Text] [Related]  

  • 12. Change of serum creatine phosphokinase activity after exercise in Duchenne type of progressive muscular dystrophy.
    Nakane K
    Nagoya Med J; 1972 Feb; 17(3):203-16. PubMed ID: 5050757
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical symptoms in a female carrier of Duchenne muscular dystrophy.
    Zatz M; Levisky RB; Levy JA; Valente BO; Gianotti M; Frota-Pessoa O
    J Genet Hum; 1973 Dec; 21(4):297-305. PubMed ID: 4792239
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of preclinical Duchenne muscular dystrophy and its female carriers.
    Beckmann R
    Isr J Med Sci; 1977 Feb; 13(2):102-6. PubMed ID: 863671
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic counseling in Duchenne muscular dystrophy.
    Bradley WG; Kelemen J
    Muscle Nerve; 1979; 2(5):325-8. PubMed ID: 492208
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum pyruvate-kinase (PK) activity during pregnancy in potential carriers for Duchenne muscular dystrophy.
    Zatz M; Passos MR; Bortolini ER
    Am J Med Genet; 1983 May; 15(1):149-51. PubMed ID: 6859115
    [No Abstract]   [Full Text] [Related]  

  • 17. [Screening for elevated creatine kinase activities for the early diagnosis of Duchenne muscular dystrophy].
    Beckmann R; Scheuerbrandt G
    Fortschr Med; 1979 Oct; 97(39):1733-6. PubMed ID: 511067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscular dystrophy: clinical, electrical, histological and biochemical study.
    Desai AD; Braganca BM; Divekar AY; Bubelis I; Deshpande DH; Rebello MD
    Neurol India; 1966; 14(4):167-73. PubMed ID: 5977713
    [No Abstract]   [Full Text] [Related]  

  • 19. [Trisomy 21 in a boy with progressive muscular dystrophy (Duchenne)].
    Moser H
    Z Kinderheilkd; 1971; 109(4):318-25. PubMed ID: 4252123
    [No Abstract]   [Full Text] [Related]  

  • 20. The significance of changes in the blood serum electrolytes in the detection of heterozygous carriers of Duchenne myopathy.
    Grinio LP
    Sov Genet; 1974 Mar; 7(12):1596-9. PubMed ID: 4827770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.